Attix Pharmaceuticals recalls Ticarcillin Sodium/Potassium Clavulanate (30:1) active pharmaceutical ingredient packaged in varying grams or kg in bag…

Recall date

November 14, 2014

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-929-2015

FDA classification

Class II

Brand / firm

Attix Pharmaceuticals

Sold / distributed

Nationwide to compounding pharmacies and research organizations.

Why it was recalled

Stability Data Does Not Support Expiry: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged without data to support the printed expiry date.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Ticarcillin Sodium/Potassium Clavulanate (30:1) active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada